Strand Life Sciences - Events

publications

Go Back

Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.

Singh J, Thota N, Singh S, Padhi S, Mohan P, Deshwal S, Sur S, Ghosh M, Agarwal A, Sarin R, Ahmed R, Almel S, Chakraborti B, Raina V, DadiReddy PK, Smruti BK, Rajappa S, Dodagoudar C, Aggarwal S, Singhal M, Joshi A, Kumar R, Kumar A, Mishra DK, Arora N, Karaba A, Sankaran S, Katragadda S, Ghosh A, Veeramachaneni V, Hariharan R,  Mannan AU* (2018)
Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.
Breast Cancer  Research  and  Treatment,  July  2018,  170(1):189–196.  doi:  10.1007/s10549-018-4726-x.  [Epub ahead of print] PMID: 29470806 [Impact factor: 3.62]

Click this link to access the complete article.

22 February, 2018

Queries ? Ask Us